Protheragen is proud to release the launch of its comprehensive vaccine development solutions tailored to advance research and development in the field of infectious diseases. This strategic initiative aims to accelerate the creation of effective vaccines to combat emerging and re-emerging infectious threats.
Infectious diseases are disorders caused by organisms — such as bacteria,...
CD BioGlyco, a leading biotechnology company specializing in glycobiology, is proud to announce its enhanced polysaccharide vaccine development services. Leveraging cutting-edge platforms and extensive expertise, CD BioGlyco is poised to support researchers and organizations in the development of safer, more effective vaccines against a wide range of infectious diseases.
...
Human papillomavirus (HPV), a common sexually transmitted infection, can beget a wide range of health problems including genital warts and cancers. Development of HPV vaccine is a major advance in guarding people against the contagion. The first HPV vaccine, Gardasil, was approved by the US Food and Drug Administration (FDA) in 2006. This vaccine protects against several...